Angela Ngai - Concepedia

Concepedia

Author

Angela Ngai

United States Military Academy

Also Known As

ANGELA L. NGAI, ANGELA NGAI, Angela L. Ngai, Angela Ngai

16

Publications

1.2K

Citations

10

H-Index

16

Concepts

All Affiliations

United States Military Academy Merck (Japan)Universitair Ziekenhuis Leuven Children's Hospital of Philadelphia The University of Texas Southwestern Medical Center

AN

About

Angela Ngai is an author at United States Military Academy specializing in pharmacotherapy, medicine, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	77
2	General Academic Pediatrics	1	1	40
3	Pharmacology	1	1	37
4	Antibiotics	1	1	37
5	Antimicrobial Pharmacodynamics	1	1	37

Angela Ngai

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy J. Maertens, Issam Raad, G. Petrikkos, Clinical Infectious Diseases	2004	659
Modified cases of chickenpox after varicella vaccination C. J. White, Barbara J. Kuter, Angela Ngai, The Pediatric Infectious Disease Journal	1992	182
A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented <i>Candida</i> or <i>Aspergillus</i> Infections in Pediatric Patients Theoklis E. Zaoutis, Hasan S. Jafri, Li‐Min Huang, PEDIATRICS	2009	109
Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children Angela Ngai, BRENDA O. STAEHLE, Barbara J. Kuter, The Pediatric Infectious Disease Journal	1996	64
SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS Theoklis E. Zaoutis, Thomas Lehrnbecher, Andreas H. Groll, The Pediatric Infectious Disease Journal Drug SafetyGeneral Academic PediatricsPatient SafetyPediatricsPediatric Patients	2009	40
Caspofungin Use in Patients with Invasive Candidiasis Caused by Common Non- <i>albicans Candida</i> Species: Review of the Caspofungin Database Arnaldo Lopes Colombo, Angela Ngai, Michael Bourque, Antimicrobial Agents and Chemotherapy	2010	40
Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients Chi‐Chung Li, Peng Sun, Yingwen Dong, Antimicrobial Agents and Chemotherapy Diagnostic MycologyFungal Cell BiologyMedicinal FungiClinical MycologyPharmacotherapy	2011	37
Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants Gary S. Marshall, Gregory L. Adams, Michael Leonardi, PEDIATRICS	2015	31
Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R®II, VARIVAX® and TETRAMUNE® in healthy children vs. concomitant injections of M-M-R®II and TETRAMUNE® followed six weeks later by VARIVAX® Henry R. Shinefield, Steven Black, BRENDA O. STAEHLE, The Pediatric Infectious Disease Journal	1998	23
A web-based endpoint adjudication system for interim analyses in clinical trials Tracy L. Nolen, Bill F Dimmick, Luis Ostrosky‐Zeichner, Clinical Trials	2009	10

Page 1